Mechanical Versus Pharmacological Prophylaxis of Deep-vein Thrombosis in Patients Undergoing Total Hip Replacement. A Randomized, Controlled Clinical Trial;Mechanische versus medikamentöse Thromboseprophylaxe nach Totalhüftendoprothesenimplantation. Eine randomisierte, kontrollierte klinische Studie

Biomedizinische Technik

Volumn 48, Issue 7-8, 2003, Pages 207-212

  Pietsch, M ^a   Kuhle J ^a   Hamer, H ^b   Pitto, R R ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

Deep vein thrombosis ; Low molecular weight heparin; Mechanical prophylaxis; Pneumatic compression; Thrombosis; Total hip arthroplasty

Indexed keywords

MOLECULAR WEIGHT; PATIENT MONITORING; TISSUE;

THROMBOSIS;

BIOLOGICAL ORGANS;

LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEVICE; DRUG EFFICACY; ECHOGRAPHY; EDEMA; FEMALE; FOOT PUMP; GERMANY; HEMATOMA; HUMAN; LEG COMPRESSION; MAJOR CLINICAL STUDY; MALE; MECHANICAL PROPHYLAXIS; POSTOPERATIVE PERIOD; PROPHYLAXIS; PUMP; THROMBOCYTOPENIA; TOTAL HIP PROSTHESIS; WOUND DRAINAGE; WOUND HEALING;

ADULT; AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BANDAGES; FEMALE; HUMANS; MALE; MIDDLE AGED; NADROPARIN; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICAL THERAPY MODALITIES; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; THROMBOCYTOPENIA; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS;

EID: 0043268046     PISSN: 00135585     EISSN: None     Source Type: Journal    
DOI: 10.1515/bmte.2003.48.7-8.207     Document Type: Article

References (25)

1. Ansell, J., D. Deykin: Heparin-induced thrombocytopenia and recurrent thromboembolism. Anier. J. Hematol. 8 (1980), 325-332.
2. Blanchard J., P. F. Meuwly, P. F. Leyvraz, M. J. Miron, H. Bounameaux, P. Hoffmeyer, D. Didier, P. A. Schneider: Prevention of deep-vein thrombosis after total knee repIacemenL Randomised comparison between a low-molecular-weight hepariu (nadroparin) and mechanical prophylaxis with a foot-pump system. J. BoneJointSurg. 81-B (1999), 654-659.
3. Clagett, G. L. P., F. A. Anderson, J. Heit, M. N. Levine, H. B. Wheeler: Prevention of venous thromboembolism. Chest. 108 (1995), 312-334.
4. Deutsche Gesellschaft für Chirurgie: Leidinien zur stationären und ambulanten Thromboembolie-Prophylaxe in der Chirurgie. Beilage zu den Mitteilungen der Deutschen Gesellschaft für Chirurgie G91, Heft 3 (2000).
5. Fordyce, M. J., R. S. Ling: A venous foot pump reduces thrombos aftn total hip rrplamncnt. J. Bone Joint Surg. 74-B (1992), 45-19.
6. Gardncr, Ë. M., K. H. Fox; The venou.s pump of t ho human foot-preliminary report. Bristol Med. Chir. J. 98 (1983), 109-112.
7. Cardner. Ë. M., R. H. Fox, C. Lawrence, T. D. Bunker: Rcductiun of posi-traumatic swdling and rompartment pressurc by impulsc romprexsion of die foot. J. Bone Joint Surg. 72-B (11190).
8. Killewich. L. A., G. P. Sandagcr, A. H. Nguyen, M.P. Lilly, W. R. Flinn: Venous hcmodynamics during impulsc åüï t pumping.J. Ytoc. Suig. 22 (1995), 098-605.
9. Mammcn, E. F.: Low molccular weight hrparins and heparin-induced iroinbo-cytopcnia. Clin, Ëññß. Thromb. Hcmost. 5 (1999), 72-75.
10. Marx. A., G. Huhlc, U. Hoflmann, L. C. Wang, B. Schule, L. Jani. J. Harenberg: Heparin-induzierte Thrombozyiopenie nach elvklnem Huftgclcnkiersatz unter einer postopera vcn Thromboembolieprophylaxe mit niedermolekularem Heparin. ‘L Orthop. 137 (1999). 536-539.
11. Murray, D. W., A. R. Britton, C.J. K. Bulstrode: Thromboprophylaxis and dcath after total hip replacemcnt. J. Bone Joint Surg. 78-8(1996), 863-870.
12. Mycrson M. S., M. R. Henderson: Clinical applicalions of a pneumatic intcrmiitent impulse compression device after trauma and major surgciy to ie foot and ankle. Foot & Ankle Int. 4(1993). 198-203.
13. Palmer, A. J., K. Koppenhagen, B. Kirchhof. U. Weber, R. Bergemann: Efficacy and safety of low molecular weight heparin, unfi-actionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery. A meta-analysis of randomized clinical trial. Haemostasis 27 (1997), 75-84.
14. Pcllegrini. V. D. Jr., D. Clement, C. Lush-Ehmann, G. S. Keller, C. M. Evarts: Natural history of thromboembolic diseasc after total hip arthroplasty. Clin. Orthop. 333 (1996), 27-40.
15. Pitto, R. P., M. Koessler, K. Draencrt: Prophylaxis of fat and bone mairow embolism in cemented total hip arthroplasty. Clin. Orthop. 355 (1998). 23-34.
16. Pitto, R. P., J. Kuehle, H. Hamer, M. Radespiel-Troger, M. Pietsch: H modynamik mit pneumatischer Fu kompression. Einflu der Beinlagerung. Biomed. Tech. 46 (2001), 124-128.
17. Santori, F. S., A. Mtullo, M. Stopponi, N. Santori, S. Ghera: Prophylaxis agaimt deep-vein thrombosis in total hip replacement Comparison of heparin and foot impulse puinp.J. Bone Joint Surg. 76-B (1992). 579-583.
18. Sharrotk, N. E., W. W. Brien, E. A. Salvati, R. Mineo, K. Garvin, T. P. Sculco: The effect of fixed-dose heparin during total hip arthrophuty on the incidence of deep-vein thrombosw. J. Bone Joint Surg. 72-A (1990), 1456-1461.
19. Stannard J. P., R. M. Harris, A. L. Bucknell, A. Cossi, J. Ward. E. D. Arringlon: Prophylaxis of dccp venous rhrombow.i after total hip arthroplasty by using intermiitent compression of the plantar venoiw plcxus. Am.J. Onhop. 25 (1996), 127-134.
20. Stōckle, U., R. Hoffmann, M. Schūlz, C. von Fournier, N. P. Sudkamp, N. Haas: Fastest reduction of posttraumadc cdema: continuous cryothcrapy or intcrmitteni impulse compression? Foot & Ankle Int. 18 (1997), 432-438.
21. Stranks, C. J., N. A. McKenzic, M. L. Grovcr, T. Fail: The A-V Impulse System rcduces deep-vein thrombosis and swclling after hemiarthroplasty for hip fracture. J. Bone Joint Surg. 74-B (1992), 775-778.
22. The RD Heparin Arthroplasty Group: RD heparin compared with warfarin for prevention of venous thromboembolic diseasc following total hip or knee arthroplasty. J, Bone Joint Surg. 76-A (1994), 1174-1185.
23. Thomas, D. P.: Does low molecular weight heparin cause lese bleeding? Thromb. Haemost. 78 (1997), 1422-1425.
24. Warwick, D., M. H. Williams. G. C. Bannisten Death and thromboembolic disease after total hip replaccment. A series of 1162 cases with no rou ne chemical prophylaxis. J, Bone Joint Surg. 77-B (1995), 6-10.
25. Warwick, D., J. Harrison, D. Glew, A. Mitchelmore, T. J. Peters, J. Donovan: Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deepvein thrombosis after total hip replacemcnt. A prospective, randomized trial. J. Bone Joint Surg. 80-A (1998). 1158-1166.